SLC6A2 and depressive disorder: Both the dopamine transporter (DAT) and the norepinephrine transporter (NET), which are subject to modulation by the Syn proteins in cellular trafficking models [13], are linked to these neuropsychiatric symptoms, and are important drug targets in the treatment of depression, anxiety, and related mood disorders [14].